AI assistant
Mankind Pharma Limited — Call Transcript 2023
May 25, 2023
61869_rns_2023-05-25_05982bf7-9670-4b04-aa6c-fd213c720a91.pdf
Call Transcript
Open in viewerOpens in your device viewer
==> picture [594 x 114] intentionally omitted <==
Date: 25[th] May 2023
BSE Limited P J Towers, Dalal Street, Mumbai – 400 001
Script Code: 543904
National Stock Exchange of India Limited Exchange Plaza, C-1, Block G, Bandra Kurla Complex, Bandra (E), Mumbai – 400 051
Symbol: MANKIND
Dear Sir/ Madam,
Subject: Intimation of Performance and Business Update Call on Q4FY23 & FY23 with Senior Management of Mankind Pharma Limited (“the Company”)
Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby inform you that the Company will host Performance and Business update call on Wednesday, 31[st] May 2023 at 12 noon (IST) for Q4FY23 & FY23.
Details of the Performance and Business update call are enclosed.
The same are also being uploaded on website of the Company at www.mankindpharma.com.
You are requested to kindly take the same on records.
Thanking You,
Yours Faithfully,
For Mankind Pharma Limited
Digitally signed Pradeep by Pradeep Chugh Chugh Date: 2023.05.25 18:49:04 +05'30'
Pradeep Chugh Company Secretary and Compliance Officer Membership No. A18711
==> picture [451 x 64] intentionally omitted <==
Investor Conference Call
==> picture [117 x 33] intentionally omitted <==
Mankind Pharma Limited
==> picture [145 x 94] intentionally omitted <==
Invites you to participate in the Company’s Q4FY23 & FY23 Performance and Business Update Call
with
Mankind Pharma’s Senior Management
On Wednesday, May 31, 2023
At 12 Noon IST
For Diamond pass please Copy this URL in your browser:
= https://services.choruscall.in/DiamondPassRegistration/register?confirmationNumber 4134984&linkSecurityString =15dc37a210
Universal Dial in +91 22 6280 1214 / +91 22 7115 8115
Local times
All India (1200 hours)
Singapore (1430 hours) Hong Kong (1430 hours) UK (0730 hours)
United States (2330 hours EST)
FACILITATED BY: KIE Pharma Team
Call Coordinator
Alankar Garude | [email protected]
CORPORATE ACCESS | Kotak Institutional Equities